Correlation Between Kezar Life and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kezar Life and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kezar Life and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kezar Life Sciences and Seres Therapeutics, you can compare the effects of market volatilities on Kezar Life and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kezar Life with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kezar Life and Seres Therapeutics.
Diversification Opportunities for Kezar Life and Seres Therapeutics
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Kezar and Seres is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Kezar Life Sciences and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Kezar Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kezar Life Sciences are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Kezar Life i.e., Kezar Life and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Kezar Life and Seres Therapeutics
Considering the 90-day investment horizon Kezar Life Sciences is expected to under-perform the Seres Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Kezar Life Sciences is 1.49 times less risky than Seres Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Seres Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 653.00 in Seres Therapeutics on August 29, 2024 and sell it today you would lose (561.00) from holding Seres Therapeutics or give up 85.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kezar Life Sciences vs. Seres Therapeutics
Performance |
| Timeline |
| Kezar Life Sciences |
| Seres Therapeutics |
Kezar Life and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kezar Life and Seres Therapeutics
The main advantage of trading using opposite Kezar Life and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kezar Life position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Kezar Life vs. Century Therapeutics | Kezar Life vs. Mineralys Therapeutics, Common | Kezar Life vs. Nkarta Inc | Kezar Life vs. Surrozen |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges |